Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Other Accumulated Expenses (2016 - 2024)

Firefly Neuroscience has reported Other Accumulated Expenses over the past 10 years, most recently at $230024.0 for Q2 2024.

  • Quarterly results put Other Accumulated Expenses at $230024.0 for Q2 2024, down 55.07% from a year ago — trailing twelve months through Jun 2024 was $230024.0 (down 55.07% YoY), and the annual figure for FY2023 was $267604.0, down 5.61%.
  • Other Accumulated Expenses for Q2 2024 was $230024.0 at Firefly Neuroscience, up from $168658.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for AIFF hit a ceiling of $816536.0 in Q1 2022 and a floor of $7656.0 in Q2 2020.
  • Median Other Accumulated Expenses over the past 5 years was $223566.0 (2023), compared with a mean of $274381.1.
  • Biggest five-year swings in Other Accumulated Expenses: crashed 86.3% in 2020 and later surged 10047.09% in 2022.
  • Firefly Neuroscience's Other Accumulated Expenses stood at $54274.0 in 2020, then soared by 276.02% to $204080.0 in 2021, then skyrocketed by 38.91% to $283497.0 in 2022, then dropped by 5.61% to $267604.0 in 2023, then dropped by 14.04% to $230024.0 in 2024.
  • The last three reported values for Other Accumulated Expenses were $230024.0 (Q2 2024), $168658.0 (Q1 2024), and $267604.0 (Q4 2023) per Business Quant data.